Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture

In an effort to identify therapeutic intervention strategies for the treatment of COVID-19, we have investigated a selection of FDA-approved small molecules and biologics that are commonly used to treat other human diseases. A investigation into 18 small molecules and 3 biologics was conducted in ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Risner, Kenneth H., Tieu, Katie V., Wang, Yafei, Getz, Michael, Bakovic, Allison, Bhalla, Nishank, Nathan, Steven D., Conway, Daniel E., Macklin, Paul, Narayanan, Aarthi, Alem, Farhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430595/
https://www.ncbi.nlm.nih.gov/pubmed/32817953
http://dx.doi.org/10.1101/2020.08.12.246389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430595/
https://www.ncbi.nlm.nih.gov/pubmed/32817953
http://dx.doi.org/10.1101/2020.08.12.246389

Ejemplares similares